Navigation Links
Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery
Date:11/8/2008

Cataract Surgery Patients can Better Understand Their Condition at CataractSurgery.com

Fort Worth, Texas (PRWEB) November 8, 2008 -- Cataract surgery patients and their caregivers now have a new online educational resource to gather information on cataracts, found at www.cataractsurgery.com. Cataracts affect nearly 20 million Americans age 60 and older and are the leading cause of treatable blindness in the world. The new website is sponsored by Alcon, Inc. (NYSE:ACL), the world's leading eye care company, which has focused on preserving, restoring and enhancing sight for more than 60 years.

"Increasingly, we find that our patients and their families are looking to the Internet for information on healthcare," said Stephen Lane, M.D. and Clinical Professor of Ophthalmology for the University of Minnesota. "CataractSurgery.com will improve communication between the patient, the physician and the practice staff, as well as allow patients to have a clearer understanding of their surgical options."

The Alcon-sponsored educational website provides information on cataracts, cataract surgery and intraocular lens (IOL) options. In addition, CataractSurgery.com includes details on preparing for an eye exam and features videos, cataract illustrations, patient testimonials and a cataract resource library.

"Our research shows that there is a need for an informational website to help patients have better discussions wi
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Alcons PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
2. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
3. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
4. ORBIS and Alcon Team Up to Provide Eye Care Education to School Students
5. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
6. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
7. Lazarex Cancer Foundation Sponsors Community Colorectal Cancer Screening at Alta Bates Summit Medical Center
8. Unique Way to Help Your Favorite Animal - Morris Animal Foundations 2009 Sponsorship Guide Provides Nearly 200 Options
9. The Dannon Company Sponsors FitFuture KIDS Fest
10. Gilbert Hospital Sponsors Queen Creek Chamber of Commerce Benefit
11. VA Announces Ten National Sponsors for New Sports Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery
Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery
(Date:7/3/2009)...y 3 Bertalan Mesko, medical blogge...guide for medical professionals focusing on how ...l conferences are expensive and patients are also ...Guide helps doctors enter a virtual realm and orga...s Second Life provides opportunities for case pres...
(Date:7/3/2009)...ivorce or death in middle age may triple the risk,...hDay News) -- Middle-aged adults who live alone ar...,s disease later in life compared to those who are...hree times higher among those who are divorced or ...innish researchers. , The study included 2,000 ...
(Date:7/3/2009)... fireworks hazards , , FRIDAY, July 3 (H... cause almost 10,000 injuries every year in the Un...lp keep you and others safe while enjoying the key...Health Inc. Corporation, which runs several Georgi... fireworks safety: , Obey all local laws regardi...
(Date:7/3/2009)...PRNewswire-Asia/ -- Sundia MediTech, a leading,in...rcing company in Shanghai,China announced today ...,President of Chemistry Services. , Prior t...osciences, a drug,discovery and development compa...cientist to Senior Director of Medicinal Chemistry...
Breaking Medicine News(10 mins):Health News:Living Alone Increases Odds of Developing Dementia 2Health News:Put Safety First on the 4th 2Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2
...nd and Amylin Pharmaceuticals has announced that ...ugar levels, at par with iphasic insulin // aspart...revealed after a threadbare study conducted by the...ering type 2 diabetes and unable to control the bl...
... are applying the same basic technique seismologis...chnology that promises to prevent stress fractures...s.// The crack formation generates waves similar ...rchers at Purdue University and the University of ...
...n’s Hospital of Philadelphia announces the establi...sciplinary resource created to diagnose//, treat a...celiac disease. “A person with celiac disease is ...redient found in many foods including bread, pasta...
...ent's campaign had failed to hand out morning-afte...ng number of teenage pregnancies.// The campaign h... Besides this the government has been accused of f...ually transmitted diseases. From 2002 it has been...
Other Medicine News:Health News:New System Monitors Tiny 'Earthquakes' in Bones to Prevent Fractures 2Health News:New System Monitors Tiny 'Earthquakes' in Bones to Prevent Fractures 3Health News:New System Monitors Tiny 'Earthquakes' in Bones to Prevent Fractures 4Health News:Center for Celiac Disease Opens 2Health News:Government Failed to Prevent Rising Teen Pregnancies 2Health News:Government Failed to Prevent Rising Teen Pregnancies 3
(Date:6/29/2009)...Biotherapeutics Based On Naturally Resected tRNA S... -- Pangu BioPharma, a subsidiary of aTyr Pharma i...rd patent application on proprietary, naturally oc...h tRNA synthetases are universal and essential com...l organisms, human synthetases have naturally occu...
(Date:6/28/2009)...tugal, June 29 Data presented,tod...t with the novel,once-daily anti-epileptic Zebin... a marked and sustained decrease in seizure freque...he one-year extension of a pivotal Eslicarbazepine...ternational Congress for Epilepsy in,Budapest, Hu...
(Date:6/26/2009)...Newswire-FirstCall/ -- Sanofi-aventis (EURONEXT:... data associated with a retrospective follow-up of...a clearly show that no definitive conclusions can ...between Lantus(R) (insulin glargine [rDNA] injecti... authors of the study point out. , , Clinical s...
(Date:6/26/2009)...proval of New Anti-TNF Therapy in Three Rheumatic ... , HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PR... and Schering-Plough Corporation (NYSE: SGP ) an...ducts for Human Use (CHMP) of the European Medicin...ending the approval of SIMPONI(TM) (golimumab) as ...
Breaking Medicine Technology:Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 1New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 2New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 3New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 4New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 5OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 1OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 2OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 3OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 4OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 5Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 1Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 2Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 3Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 4Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 5Wyeth Donates 24100 000 to ASCO Cancer Foundation 28R 29 to Support Cancer Prevention and Care 47367 1Wyeth Donates 24100 000 to ASCO Cancer Foundation 28R 29 to Support Cancer Prevention and Care 47367 2Wyeth Donates 24100 000 to ASCO Cancer Foundation 28R 29 to Support Cancer Prevention and Care 47367 3
...NGTON, March 15, 2007 /PRNewswire/ -- Up to two mi...h up to 600,000,hospitalized. Its primary complica...0 lives annually -- more than breast cancer and,AI...Thrombosis (DVT) recently,sponsored an online surv...ers and physicians. The survey, which was conducte...
...ng-Plough Announces Presentation Of Phase II Trial...st At The 2007 Annual,Meeting Of The American Coll...ch 16, 2007 /PRNewswire-FirstCall/ --,Schering-Plo...e,Phase II trial of its novel oral thrombin recept...t the 2007 annual Scientific Sessions,of the of Ca...
Other Medicine Technology:DVT Awareness Survey Findings for Respondents in High-Risk Groups:,Obese Individuals 2Media Advisory: ACC Updated Schedule 2
Siemens Video: Smart Heart Scans for Athletes
The VPAP III ST-A combines the exclusive features of the popular VPAP III series with adjustable trigger and cycle thresholds and a full range of clinician and patient-friendly alarms in a new, strea
Siemens Webcast: Cardiovascular Computed Tomography (CVCT): A Cardiologists Perspective
GeroFlex reusable catheters for 24-hour esophageal pH monitoring. , ,The GeroFlex esophageal pH catheters are reusable up to five times. They are constructed of the same high quality materials as t
Medicine Products: